Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 17;24(1):53.
doi: 10.1186/s12888-023-05469-2.

Systemic inflammatory biomarkers in Schizophrenia are changed by ECT administration and related to the treatment efficacy

Affiliations

Systemic inflammatory biomarkers in Schizophrenia are changed by ECT administration and related to the treatment efficacy

Yu Wang et al. BMC Psychiatry. .

Abstract

Immune inflammation has long been implicated in the pathogenesis of schizophrenia. Despite as a rapid and effective physical therapy, the role of immune inflammation in electroconvulsive therapy (ECT) for schizophrenia remains elusive. The neutrophils to lymphocytes (NLR), platelets to monocytes (PLR) and monocytes to lymphocytes (MLR) are inexpensive and accessible biomarkers of systemic inflammation. In this study, 70 schizophrenia patients and 70 age- and sex-matched healthy controls were recruited. The systemic inflammatory biomarkers were measured before and after ECT. Our results indicated schizophrenia had significantly higher peripheral NLR, PLR and MLR compared to health controls at baseline, while lymphocytes did not differ. After 6 ECT, the psychiatric symptoms were significantly improved, as demonstrated by the Positive and Negative Syndrome Scale (PANSS). However, there was a decline in cognitive function scores, as indicated by the Mini-Mental State Examination (MMSE). Notably, the neutrophils and NLR were significantly reduced following ECT. Although lymphocytes remained unchanged following ECT, responders had significantly higher lymphocytes compared to non-responders. Moreover, the linear regression analyses revealed that higher lymphocytes served as a predictor of larger improvement in positive symptom following ECT. Overall, our findings further highlighted the presence of systemic inflammation in schizophrenia patients, and that ECT may exert a therapeutic effect in part by attenuating systemic inflammation. Further research may therefore lead to new treatment strategies for schizophrenia targeting the immune system.

Keywords: Electroconvulsive therapy; Inflammation; Lymphocytes; NLR; Neutrophils; Schizophrenia.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interests to declare.

Figures

Fig. 1
Fig. 1
Differences in systemic inflammatory biomarkers in schizophrenia and controls and changes following ECT. Data was expressed as mean ± standard deviation (SD). a PLT was significantly elevated in schizophrenia compared to healthy controls (HCs) but remained stable following ECT. b Neutrophils was significantly elevated in schizophrenia and reduced following ECT. c Lymphocytes showed no differences between schizophrenia and HCs and kept stable following ECT. d Monocytes were significantly elevated in schizophrenia and decreased following ECT. e the neutrophil-to-lymphocyte ratio (NLR) was significantly higher in schizophrenia and reduced following ECT. f the PLT-to-lymphocyte ratio (PLR) was elevated in schizophrenia, while demonstrated no differences following ECT. g the monocytes- to-lymphocyte ratio (MLR) was higher in schizophrenia and significantly downregulated following ECT. *p < 0.05, **p < 0.01, ***p < 0.001, **** p < 0.0001

Similar articles

Cited by

References

    1. Weye N, Santomauro DF, Agerbo E, Christensen MK, Iburg KM, Momen NC, Mortensen PB, Pedersen CB, Whiteford HA, McGrath JJ, et al. Register-based metrics of years lived with disability associated with mental and substance use disorders: a register-based cohort study in Denmark. The Lancet Psychiatry. 2021;8(4):310–9. doi: 10.1016/S2215-0366(21)00029-8. - DOI - PubMed
    1. Estes ML, McAllister AK. Maternal immune activation: implications for Neuropsychiatric Disorders. Science. 2016;353(6301):772–7. doi: 10.1126/science.aag3194. - DOI - PMC - PubMed
    1. Park GH, Noh H, Shao Z, Ni P, Qin Y, Liu D, Beaudreault CP, Park JS, Abani CP, Park JM, et al. Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia. Nat Neurosci. 2020;23(11):1352–64. doi: 10.1038/s41593-020-00724-1. - DOI - PMC - PubMed
    1. Szabo A, O’Connell KS, Ueland T, Sheikh MA, Agartz I, Andreou D, Aukrust P, Boye B, Boen E, Drange OK, et al. Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain Behav Immun. 2022;99:299–306. doi: 10.1016/j.bbi.2021.10.017. - DOI - PubMed
    1. Nunez C, Stephan-Otto C, Usall J, Bioque M, Lobo A, Gonzalez-Pinto A, Pina-Camacho L, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, et al. Neutrophil Count is Associated with reduced Gray Matter and Enlarged ventricles in First-Episode Psychosis. Schizophr Bull. 2019;45(4):846–58. doi: 10.1093/schbul/sby113. - DOI - PMC - PubMed

Publication types